Which community-based programs resulted in equally favorable health risk changes for both con-trol and treatment groups? (Select all that apply.)
a. Framingham Heart Study
b. Stanford Five-City Heart Disease Preven-tion Program
c. North Karelia Study
d. Minnesota Heart Health Program
e. Dutch Heart Health Community Interven-tion
ANS: B, C, D, E
The Stanford Five-City Heart Disease Prevention Program, North Karelia Study, Minnesota Heart Health Program, and Dutch Heart Health Community Intervention provided beginning scientific evidence for the implementation of community-level risk reduction programs, although the results were modest and often not statistically significant. The Framingham Heart Study identified factors contributing to the development of CHD and high blood pressure.
You might also like to view...
When reviewing the phases of drug development, the nurse finds a discussion about the postmarketing surveillance phase. Which one of the following activities would the nurse expect to find as being carried out during this phase?
A) Health care providers report adverse effects to FDA. B) Healthy volunteers are involved in the test. C) In vitro tests are performed using human cells. D) The drug is given to patients with the disease.
The nurse notes that a patient's blood pressure has been trending lower since admission. Which intervention demonstrates the nurse using information to guide nursing care? Select all that apply.
A) Measuring body temperature B) Measuring intake and output C) Monitoring for blood in stool D) Monitoring for blood in urine E) Monitoring level of consciousness
__________ involves the obstruction of one of the pulmonary arteries or its branches
Fill in the blank(s) with correct word
A patient has a normal cardiac rhythm and a heart rate of 72 beats/minute. The nurse determines that the P-R interval is 0.24 seconds. The most appropriate intervention by the nurse would be to
a. notify the health care provider immediately. b. give atropine per agency dysrhythmia protocol. c. prepare the patient for temporary pacemaker insertion. d. document the finding and continue to monitor the patient.